Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1 domain family member 3 pseudogenes are non-coding genomic sequences highly homologous to the active TBC1D3 gene, which originally arose from primate-specific gene duplication events[1][3]. While the TBC1D3 protein functions in macropinocytosis and cell signaling, these pseudogenes lack open reading frames capable of producing functional proteins. Pseudogene copies are typically not transcribed or translated, and do not encode regulatory or catalytic activity. Thus, "ENSG00000229286" and similar entries are not considered druggable targets, receptors, enzymes, or transporters. Their sole relevance may be as potential molecular markers in genomic studies or for mapping evolutionary events[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 3 pseudogene.